Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond
It remains a challenge for the effective treatment of neuroinflammatory disease, including multiple sclerosis (MS), stroke, epilepsy, and Alzheimer’s and Parkinson’s disease. The voltage-gated potassium Kv1.3 channel is of interest, which is considered as a novel therapeutic target for treating neur...
Main Authors: | Xiaoli Wang, Guoyi Li, Jingkang Guo, Zhiping Zhang, Shuzhang Zhang, Yudan Zhu, Jiwei Cheng, Lu Yu, Yonghua Ji, Jie Tao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-01-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnins.2019.01393/full |
Similar Items
-
Corrigendum: Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond
by: Xiaoli Wang, et al.
Published: (2020-02-01) -
ShK-Domain-Containing Protein from a Parasitic Nematode Modulates <i>Drosophila melanogaster</i> Immunity
by: Aklima K. Lima, et al.
Published: (2022-09-01) -
Trabectedin modulates macrophage polarization in the tumor-microenvironment. Role of KV1.3 and KV1.5 channels
by: Diego A. Peraza, et al.
Published: (2023-05-01) -
Blockade of Kv1.3 Potassium Channel Inhibits Microglia-Mediated Neuroinflammation in Epilepsy
by: Xinyi Zhang, et al.
Published: (2022-11-01) -
Neuroinflammatory Hypothesis in Major Depressive Disorder
by: Gulfizar Sozeri-Varma
Published: (2014-02-01)